A298060 logo

Poongjeon Pharmacy CO.,LTD. Stock Price

KOSDAQ:A298060 Community·₩41.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A298060 Share Price Performance

₩4,635.00
-35.00 (-0.75%)
₩4,635.00
-35.00 (-0.75%)
Price ₩4,635.00

A298060 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
1 Reward

Poongjeon Pharmacy CO.,LTD. Key Details

₩1.5b

Revenue

₩1.0b

Cost of Revenue

₩518.5m

Gross Profit

₩8.8b

Other Expenses

-₩8.2b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-931.80
33.60%
-533.88%
0%
View Full Analysis

About A298060

Founded
2014
Employees
n/a
CEO
Byeong-gwan Son
WebsiteView website
www.scmlifescience.co.kr

POONGJEON PHARMACY CO.,LTD. operates as a stem cell therapy company in South Korea. It develops SCM-AGH, a treatment for moderate to severe acute pancreatitis and moderate to severe atopic dermatitis, as well as chronic graft versus host disease; and Iroro Deerscalp, a toothbrush cosmetic for hair loss relief. The company was formerly known as SCM Lifescience Co., Ltd. and change its name to POONGJEON PHARMACY CO.,LTD. in April 2026. The company was incorporated in 2014 and is headquartered in Incheon, South Korea.

Recent A298060 News & Updates

Recent updates

No updates